Cancer Biomarkers Market - Top Companies and Manufacturers

Companies Dominating the Cancer Biomarkers Landscape

INOVIQ
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
Bio-Rad Laboratories, Inc.
Abbott Laboratories
Becton, Dickinson and Company
Merck KGaA
CENTOGENE GmbH
PerkinElmer Inc.
Siemens Healthcare GmbH
F. Hoffmann-La Roche Ltd
Bristol Myers Squibb Company (BMS)

Browse Key Market Insights with Data Illustration:

Cancer Biomarkers Market Size & Share | Growth Trends 2037

In the News

Bio-Rad Laboratories, Inc. launched Bio-Plex Pro Human Cytokine Screening Panel, the first validated high-performance multiplex assay. The panel can detect and calculate 48 different analytes associated with heart disease, allergy, cancer, autoimmunity, and others.
F. Hoffmann-La Roche Ltd’s VENTANA FOLR1 (FOLR1-2.1) RxDx Assay, has been approved by the FDA and is designed to help identify patients with epithelial ovarian cancer (EOC) who are suitable for treatment with ELAHERE (mirvetuximab soravtansine-gynx). The results of this test will allow clinicians to make better treatment decisions for patients with ovarian cancer.

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of cancer biomarkers is evaluated at USD 18.65 billion.

The cancer biomarkers market size was over USD 16.8 billion in 2024 and is anticipated to exceed USD 90.3 billion by the end of 2037, growing at over 13.7% CAGR during the forecast period i.e., between 2025-2037. Growing prevalence of cancer, elevating R & D activities and investments, rising use of biomarkers in the medical sector will boost the market growth.

North America industry is expected to dominate largest revenue share by 2037, due to rising population count & growing research activities, followed by the surging ratio of health insurance covering various cancer biomarker diagnoses in the region.

The major players in the market include INOVIQ, Bio-Rad Laboratories, Inc., Abbott Laboratories, Becton, Dickinson and Company, Merck KGaA, CENTOGENE GmbH, PerkinElmer Inc., Siemens Healthcare GmbH, F. Hoffmann-La Roche Ltd, Bristol Myers Squibb Company (BMS).

Cancer Biomarkers Market - Top Companies and Manufacturers

Companies Dominating the Cancer Biomarkers Landscape

Browse Key Market Insights with Data Illustration:

In the News

Frequently Asked Questions (FAQ)

How big is the cancer biomarkers market?

What are the factors driving the cancer biomarkers landscape?

Which region held the largest cancer biomarkers industry share?

Who are the key players in the cancer biomarkers sector?